Delivery Order SPE2DB20D2014-SPE2DB24FB98H
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml. The contract has a firm fixed price of $4,717.94 and a completion date of December 4, 2024. It is designated as a delivery order contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Pulmozyme 1 mg/ml ampul 2.5 ml. The contract has a ceiling value of $20,964.92 and a completion date of May 27, 2022. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $91,225.17 Firm Fixed Price delivery order is for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml, a medication used in the treatment of cystic fibrosis. The contract has an ultimate completion date of March 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $68,193.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml). The contract has a firm fixed price and an ultimate completion date of August 14, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order under its Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a...
- This federal contract award is for the delivery of Pulmozyme 1 mg/ml ampuls, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $7,941.03 and an ultimate completion date of October 12, 2023. It is a Firm Fixed Price Delivery Order contract, without any set-aside designation. Amerisourcebergen...
- This federal contract award is for the delivery of Pulmozyme 1 mg/ml ampuls (2.5 ml) to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,410.99, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and has a completion date of July 30, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- This federal contract award is for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 19, 2024. The contract has a ceiling value of $8,233.71 and an ultimate completion date of December 20, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml, a specialty medication. The $5,231 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 28, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/ml ampul 2.5ml. The contract has a ceiling value of $9,086.35 and a period of performance through August 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Pulmozyme 1 mg/ml ampul 2.5 ml. The contract has a ceiling value of $21,236.76 and a period of performance through April 1, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB98HDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Pulmozyme (dornase alfa) medication in 2.5 ml ampules. The contract has a ceiling value of $2,546.49 and is a Delivery Order with a Firm Fixed Price pricing type. The ultimate completion date is May 23, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a broad range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific contract award appears to be an individual order made against that larger IDC. There is no set-aside designation mentioned for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 5/22/24 |